AKYA Logo

Akoya Biosciences, Inc. (AKYA) 

NASDAQ
Market Cap
$123.41M
Sector
Healthcare
Industry
Medical—Instruments & Supplies
Rank in Sector
523 of 960
Rank in Industry
30 of 49

Largest Insider Buys in Sector

AKYA Stock Price History Chart

AKYA Stock Performance

About Akoya Biosciences, Inc.

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue …

Insider Activity of Akoya Biosciences, Inc.

Over the last 12 months, insiders at Akoya Biosciences, Inc. have bought $0 and sold $104,979 worth of Akoya Biosciences, Inc. stock.

On average, over the past 5 years, insiders at Akoya Biosciences, Inc. have bought $6.53M and sold $679,875 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $92,014 was made by Pla Frederic (Chief Operating Officer) on 2023‑09‑07.

List of Insider Buy and Sell Transactions, Akoya Biosciences, Inc.

2024-06-11SalePresident and CEO
7,500
0.0145%
$2.08$15,630+12.33%
2024-06-06SalePresident and CEO
7,500
0.0146%
$2.01$15,064+17.46%
2024-03-20SalePresident and CEO
7,500
0.015%
$4.97$37,243-47.62%
2024-03-13SalePresident and CEO
7,500
0.0155%
$4.94$37,043-45.31%
2023-12-19SalePresident and CEO
7,500
0.0146%
$4.48$33,566-33.19%
2023-12-12SalePresident and CEO
7,500
0.0152%
$4.25$31,871-24.88%
2023-11-20SalePresident and CEO
7,500
0.0155%
$4.39$32,901-10.71%
2023-09-07PurchaseChief Operating Officer
20,000
0.0412%
$4.60$92,014-6.17%
2023-09-07PurchaseChief Operating Officer
13,000
0.0268%
$4.60$59,814-6.17%
2023-06-12Purchasedirector
2.02M
4.8443%
$5.00$10.1M-13.79%
2023-06-12Purchasedirector
203,388
0.4878%
$5.00$1.02M-13.79%
2023-06-12Purchasedirector
120,000
0.2878%
$5.00$600,000-13.79%
2023-06-12Purchasedirector
20,000
0.048%
$5.00$100,000-13.79%
2023-06-12Purchasedirector
20,000
0.048%
$5.00$100,000-13.79%
2023-06-12PurchaseCFO
20,000
0.048%
$5.00$100,000-13.79%
2023-06-06SalePresident/CEO
5,000
0.0131%
$5.71$28,537-16.67%
2023-03-14SalePresident/CEO
5,000
0.0135%
$9.17$45,852-39.18%
2022-12-14SaleChief Financial Officer
14,574
0.0386%
$12.46$181,519-45.72%
2022-12-13Saledirector
71,050
0.1938%
$13.03$925,782-46.46%
2022-12-13Saledirector
100
0.0003%
$13.25$1,325-46.46%

Insider Historical Profitability

<0.0001%
Raffin Thomas A.director
15937535
32.1559%
$2.4910<0.0001%
Winkler Matthewdirector
984513
1.9864%
$2.4910<0.0001%
SHEPLER ROBERT Gdirector
369592
0.7457%
$2.4920<0.0001%
Mendel Scottdirector
28500
0.0575%
$2.4920<0.0001%
Ramachandran Niro Ph.DChief Business Officer
25073
0.0506%
$2.4920<0.0001%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Blue Water Life Science Advisors Llc$22.03M9.514.7M0%+$020.72
Polar Capital$7.41M3.21.58M0%+$00.04
The Vanguard Group$6.82M2.951.45M+3.28%+$216,354.40<0.0001
BlackRock$6.32M2.731.35M-1.8%-$115,810.17<0.0001
Parkman Healthcare Partners Llc$4.3M1.86917,442+35.96%+$1.14M0.54
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.